Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919085 | Radiotherapy and Oncology | 2012 | 8 Pages |
Abstract
We showed for the first time that CAR is a marker of CSCs and may affect the activities of CSCs in treatment-resistant NSCLC. CAR may prove to be a target for CSC treatment and a predictor of treatment response in patients with NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Xiaochun Zhang, Bingliang Fang, Radhe Mohan, Joe Y. Chang,